SMART Use of Medication for the Treatment of Adolescent Severe Obesity
Status:
Recruiting
Trial end date:
2025-08-31
Target enrollment:
Participant gender:
Summary
This study will examine the timing and sequence of using adjunct obesity pharmacotherapy for
adolescents with severe obesity who do not respond to lifestyle modification therapy alone.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institutes of Health (NIH)